Review
Published on 09 Nov 2023
Antidepressant pharmacological mechanisms: focusing on the regulation of autophagy
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1287234
- 4,601 views
- 4 citations
Type at least 3 characters
2,433 articles
Original Research
Published on 09 Nov 2023
Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1264591
- 1,466 views
- 1 citation
Correction
Published on 09 Nov 2023
Corrigendum: Could peripheral 5-HT level be used as a biomarker for depression diagnosis and treatment? A narrative minireview
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1318433
- 922 views
Original Research
Published on 07 Nov 2023
Features and mechanisms of propofol-induced protein kinase C (PKC) translocation and activation in living cells
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1284586
- 2,012 views
- 3 citations
Editorial
Published on 01 Nov 2023
Editorial: Novel therapeutic approaches to treat neuroinflammation in the central nervous system
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1326774
- 1,162 views
Original Research
Published on 01 Nov 2023
Si-Ni-San alleviates early life stress-induced depression-like behaviors in adolescence via modulating Rac1 activity and associated spine plasticity in the nucleus accumbens
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1274121
- 2,719 views
- 5 citations
Original Research
Published on 01 Nov 2023
TED—trazodone effectiveness in depression: a naturalistic study of the effeciveness of trazodone in extended release formulation compared to SSRIs in patients with a major depressive disorder
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1296639
- 5,821 views
- 7 citations
Original Research
Published on 31 Oct 2023
Ketamine promptly normalizes excess norepinephrine and enhances dopamine neuronal activity in Wistar Kyoto rats
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1276309
- 3,336 views
- 4 citations
Original Research
Published on 26 Oct 2023
“Tranq-dope” overdose and mortality: lethality induced by fentanyl and xylazine
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1280289
- 6,467 views
- 27 citations
Review
Published on 25 Oct 2023
Dysregulated neuromodulation in the anterior cingulate cortex in chronic pain
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1289218
- 4,673 views
- 7 citations
Systematic Review
Published on 24 Oct 2023
A systematic review of the neuropathology and memory decline induced by monosodium glutamate in the Alzheimer’s disease-like animal model
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1283440
- 11,690 views
- 12 citations
Original Research
Published on 19 Oct 2023
Network pharmacology‒based analysis of marine cyanobacteria derived bioactive compounds for application to Alzheimer’s disease
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1249632
- 4,078 views
- 2 citations
Original Research
Published on 18 Oct 2023
Temperature modulates PVN pre-sympathetic neurones via transient receptor potential ion channels
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1256924
- 2,617 views
Original Research
Published on 18 Oct 2023
The Nociceptin/Orphanin FQ peptide receptor antagonist, SB-612111, improves cerebral blood flow in a rat model of traumatic brain injury
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1272969
- 2,316 views
- 2 citations
Case Report
Published on 18 Oct 2023
Case report: Extrapontine myelinolysis combined with flupentixol- and melitracen-induced dysphagia
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1266296
- 2,649 views
- 2 citations
Review
Published on 17 Oct 2023
Pharmacological intervention of curcumin via the NLRP3 inflammasome in ischemic stroke
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1249644
- 4,389 views
- 10 citations